SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-012597
Filing Date
2020-11-04
Accepted
2020-11-04 17:21:04
Documents
75
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20200930x10q.htm   iXBRL 10-Q 2101126
2 EX-31.1 ptgx-20200930xex31d1.htm EX-31.1 10124
3 EX-31.2 ptgx-20200930xex31d2.htm EX-31.2 9950
4 EX-32.1 ptgx-20200930xex32d1.htm EX-32.1 9500
  Complete submission text file 0001558370-20-012597.txt   8100389

Data Files

Seq Description Document Type Size
5 EX-101.SCH ptgx-20200930.xsd EX-101.SCH 58303
6 EX-101.CAL ptgx-20200930_cal.xml EX-101.CAL 53933
7 EX-101.DEF ptgx-20200930_def.xml EX-101.DEF 210275
8 EX-101.LAB ptgx-20200930_lab.xml EX-101.LAB 467205
9 EX-101.PRE ptgx-20200930_pre.xml EX-101.PRE 393178
10 EXTRACTED XBRL INSTANCE DOCUMENT ptgx-20200930x10q_htm.xml XML 1418240
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 201287697
SIC: 2834 Pharmaceutical Preparations